Headshot of André Fenton.

André Fenton

Professor, New York University
Contributing editor, The Transmitter

André Fenton is professor of neural science and director of the Center for Neural Science at New York University. He investigates the molecular, neural, behavioral and computational aspects of memory. He studies how brains store experiences as memories, how they learn to learn, and how knowing activates relevant information without activating what is irrelevant. These investigations are founded in how the brain computes knowledge of space, particularly the locations and directions that are the framework for experience. His investigations integrate across levels of biological organization; his research uses genetic, molecular, electrophysiological, imaging, behavioral, engineering and theoretical methods. This computational psychiatry research is helping to elucidate mental dysfunction in diverse conditions, including schizophrenia, autism, and depression.

Fenton founded BioSignal Group, Corp., which commercialized an FDA-approved portable, wireless and easy-to-use platform for recording EEGs in novel medical applications. He implemented a CPAP-oxygen-helmet treatment for COVID-19 in Nigeria and other low- and middle-income countries, and he develops information technology for the patient-centric coordination of behavioral health services that is desperately needed to equitably deliver care for mental health. Fenton hosted PBS’ “NOVA Wonders,” and he chairs the National Institute of Mental Health’s Board of Scientific Counselors.

Explore more from The Transmitter

Autism scientists push back on CDC’s inaccurate vaccine claims

The CDC website now falsely suggests that autism-vaccine research is still an open question, prompting distrust among researchers—some of whom anticipate “more unreliable statements coming from the junta that took over” the agency.

By The Transmitter
21 November 2025 | 6 min read

Gene replacement therapy normalizes some traits in SYNGAP1 model mice

The first published virus-based gene therapy for SYNGAP1 deletion yields benefits despite the gene’s long length and complexity.

By Charles Q. Choi
20 November 2025 | 5 min read

Does AI understand what it produces? Henk de Regt explores how we might assess understanding in machines and humans

Building on his philosophy of how scientists understand what they work on, de Regt is extending his approach to test understanding in machines.

By Paul Middlebrooks
19 November 2025 | 1 min read

privacy consent banner

Privacy Preference

We use cookies to provide you with the best online experience. By clicking “Accept All,” you help us understand how our site is used and enhance its performance. You can change your choice at any time. To learn more, please visit our Privacy Policy.